Capital Solutions Closes $17 Million Financing For Sponsored Emergency Surgical Services Company

The Capital Solutions Group (“Capital Solutions”) announces the closing of a  $17 million term loan to refinance debt held by a private equity sponsor to one of its portfolio companies providing emergency surgical services to community hospitals (the “Company”).  Capital Solutions acted as the exclusive financial advisor to the Company for the financing.

“The Company selected Capital Solutions for its track record of success executing for private equity sponsored companies in the middle market,” commented Brad Stewart, Partner, who led the financing for Capital Solutions. “Having pioneered an innovative business model with few known competitors, the Company sought a value-added advisor who could articulate the operating and financial merits of its unique business model to prospective lenders with the ultimate goal of selecting an attractive financing package to refinance its debt.  In addition to reducing the cost of its debt, the Company also required maintaining future operating flexibility to continue to grow its business, and we were pleased that we were able to successfully deliver on these expectations in accomplishing the refinancing.”

If you are a private equity sponsor or an owner-entrepreneur of a business contemplating a debt financing and would like to have several options from which to choose the one that best meets your objectives, please contact any of the Capital Solutions professionals listed below to learn how we can add value to your company’s financing.

About The Capital Solutions Group:  We provide creative financial advisory services to closely-held Companies, Private Equity Sponsors, and Lenders in the Middle Market.  Our services include: Debt Capital Raising, Recapitalizations, Financial Restructurings, and selected M&A assignments.  Since our founding in 2009, we have advised on over $1.5 billion of debt issuance, financial restructuring, and strategic advisory assignments; these transactions have been executed primarily for private equity sponsored companies.